Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression
Authors
Inbal Wortzel ; Yura Seo ; Ife Akano ; Lee Shaashua ; Gabriel Cardial Tobias ; Jakob Hebert ; Kyung-A Kim ; DooA Kim ; Shani Dror ; Yanshen Liu ; Griffin Campbell Azrak ; Michele Cioffi ; Kofi Ennu Johnson ; Tammy Hennika ; Meshulam Zisha Twerski ; Alexis Kushner ; Robert Math ; Yoon Dae Han ; Dai Hoon Han ; Minsun Jung ; Juyeong Park ; Soonmyung Paik ; Jeon-Soo Shin ; Min Goo Lee ; Marco Vincenzo Russo ; Daniel Zakheim ; Jesse Barnes ; Sunjoy Mehta ; Katia Manova ; Robert E. Schwartz ; Basant Kumar Thakur ; Nancy Boudreau ; Irina Matei ; Haiying Zhang ; Simone Sidoli ; Jacqueline Bromberg ; Yael David ; Han Sang Kim ; David Lyden
Extracellular vesicles (EVs) transport biomolecules that mediate intercellular communication. We previously showed that EVs contain DNA (EV-DNA) representing the entire genome. However, the mechanism of genomic EV-DNA packaging and its role in cancer remain elusive. We now demonstrate that EV-DNA is predominantly localized on the vesicle surface and associated with uniquely modified and cleaved histones. Moreover, a genome-wide clustered regularly interspaced short palindromic repeats knockout screen revealed that immune developmental pathways and genes, including apoptotic peptidase activating factor 1 (APAF1) and neutrophil cytosolic factor 1 (NCF1), regulate EV-DNA packaging. Furthermore, in colorectal cancer models, uptake of EV-DNA by pre-metastatic liver Kupffer cells (KCs) activated DNA damage responses. This activation rewired KC cytokine production and promoted the formation of tertiary lymphoid structures, thereby suppressing liver metastasis. Conversely, loss of APAF1 decreased EV-DNA packaging and promoted liver metastasis. Importantly, colorectal cancer biopsy EV-DNA secretion could serve as a predictive biomarker for postoperative metastasis. Taken together, our findings indicate that uniquely chromatinized EV-DNA induces antitumor immunity.